96 related articles for article (PubMed ID: 16366598)
21. Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis.
D'Andrea MR; Mei JM; Tuman RW; Galemmo RA; Johnson DL
Mol Cancer Ther; 2005 Aug; 4(8):1198-204. PubMed ID: 16093435
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity.
Gross D; Bernhardt G; Buschauer A
J Cancer Res Clin Oncol; 2006 Sep; 132(9):589-99. PubMed ID: 16736141
[TBL] [Abstract][Full Text] [Related]
23. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells.
Lo HM; Hung CF; Tseng YL; Chen BH; Jian JS; Wu WB
Biochem Pharmacol; 2007 Jun; 74(1):54-63. PubMed ID: 17449016
[TBL] [Abstract][Full Text] [Related]
24. Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
George D
Semin Oncol; 2001 Oct; 28(5 Suppl 17):27-33. PubMed ID: 11740804
[TBL] [Abstract][Full Text] [Related]
25. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
Shimizu A; O'Brien KP; Sjöblom T; Pietras K; Buchdunger E; Collins VP; Heldin CH; Dumanski JP; Ostman A
Cancer Res; 1999 Aug; 59(15):3719-23. PubMed ID: 10446987
[TBL] [Abstract][Full Text] [Related]
26. Effects of KTJ740, a novel antithrombotic agent, on platelet-derived growth factor-induced rat aortic smooth muscle cell proliferation and cell cycle progression.
Kim TJ; Jeon J; Jin YR; Son DJ; Yoo HS; Hong JT; Ryu CK; Shin HS; Lee KH; Yun YP
J Cardiovasc Pharmacol; 2007 May; 49(5):280-6. PubMed ID: 17513946
[TBL] [Abstract][Full Text] [Related]
27. Involvement of phosphatidylinositide 3'-kinase and Rac in platelet-derived growth factor-induced actin reorganization and chemotaxis.
Hooshmand-Rad R; Claesson-Welsh L; Wennström S; Yokote K; Siegbahn A; Heldin CH
Exp Cell Res; 1997 Aug; 234(2):434-41. PubMed ID: 9260914
[TBL] [Abstract][Full Text] [Related]
28. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.
Buchdunger E; Cioffi CL; Law N; Stover D; Ohno-Jones S; Druker BJ; Lydon NB
J Pharmacol Exp Ther; 2000 Oct; 295(1):139-45. PubMed ID: 10991971
[TBL] [Abstract][Full Text] [Related]
29. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
[TBL] [Abstract][Full Text] [Related]
30. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
31. Tyr1009 and Tyr1021 in the platelet-derived growth factor beta-receptor mediate agonist triggered calcium signalling.
Ridefelt P; Siegbahn A
Anticancer Res; 1998; 18(3A):1819-25. PubMed ID: 9673410
[TBL] [Abstract][Full Text] [Related]
32. Zedoariae rhizoma and curcumin inhibits platelet-derived growth factor-induced proliferation of human hepatic myofibroblasts.
Park SD; Jung JH; Lee HW; Kwon YM; Chung KH; Kim MG; Kim CH
Int Immunopharmacol; 2005 Mar; 5(3):555-69. PubMed ID: 15683851
[TBL] [Abstract][Full Text] [Related]
33. Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth.
Iwamoto H; Nakamuta M; Tada S; Sugimoto R; Enjoji M; Nawata H
J Lab Clin Med; 2000 May; 135(5):406-12. PubMed ID: 10811056
[TBL] [Abstract][Full Text] [Related]
34. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3.
Kanaki T; Bujo H; Mori S; Yanjuan Z; Takahashi K; Yokote K; Morisaki N; Saito Y
Biochem Biophys Res Commun; 2002 Jun; 294(2):231-7. PubMed ID: 12051699
[TBL] [Abstract][Full Text] [Related]
36. Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251.
Andrejauskas-Buchdunger E; Regenass U
Cancer Res; 1992 Oct; 52(19):5353-8. PubMed ID: 1394140
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
39. Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase.
Mahboobi S; Uecker A; Sellmer A; Cénac C; Höcher H; Pongratz H; Eichhorn E; Hufsky H; Trümpler A; Sicker M; Heidel F; Fischer T; Stocking C; Elz S; Böhmer FD; Dove S
J Med Chem; 2006 Jun; 49(11):3101-15. PubMed ID: 16722630
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
Liegl B; Leithner A; Bauernhofer T; Windhager R; Guelly C; Regauer S; Beham A
Histopathology; 2006 Dec; 49(6):576-81. PubMed ID: 17163842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
